Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$2.50 CAD
Change Today 0.00 / 0.00%
Volume 0.0
MPH On Other Exchanges
As of 4:11 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

medicure inc (MPH) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/28/14 - C$2.97
52 Week Low
01/30/15 - C$1.20
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDICURE INC (MPH)

Related News

No related news articles were found.

medicure inc (MPH) Related Businessweek News

No Related Businessweek News Found

medicure inc (MPH) Details

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapeutics in Canada, the United States, and Barbados. It primarily markets and sells AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction, as well as AGGRASTAT high-dose bolus regimen for the reduction of thrombotic cardiovascular events in patients with non-ST elevated acute coronary syndrome. The company is also developing TARDOXAL that is in Phase IIa clinical trials for the treatment of tardive dyskinesia/neurological indications; and Transdermal AGGRASTAT, which is in a preclinical stage for acute cardiology. Medicure Inc. was founded in 1997 and is headquartered in Winnipeg, Canada.

Founded in 1997

medicure inc (MPH) Top Compensated Officers

Founder, Chairman and Chief Executive Officer
Total Annual Compensation: C$105.0K
President and Chief Operating Officer
Total Annual Compensation: C$102.5K
Chief Financial Officer and Secretary
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

medicure inc (MPH) Key Developments

Medicure Inc. Closes $4 Million Private Placement

Medicure Inc. has closed its previously announced bought deal private placement financing raising gross proceeds of approximately $4 million.

Medicure Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Medicure Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported product sales, net of CAD 3,338,156 compared to CAD 1,639,662 for the quarter ended February 28, 2014. Operating income was CAD 480,310 compared to CAD 495,612 for the quarter ended February 28, 2014. Net income was CAD 100,151 or CAD 0.01 per basic and diluted share compared to CAD 86,420 or CAD 0.01 per basic and diluted share for the quarter ended February 28, 2014. Cash flows from operating activities were CAD 788,503 compared to CAD 35,485 for the quarter ended February 28, 2014. Acquisition of property and equipment was CAD 31,444. Earnings before interest, taxes, depreciation and amortization adjusted for share-based compensation for the first quarter ended March 31, 2015 was CAD 1.1 million compared to CAD 638,000 for the quarter ended February 28, 2014. The increase in revenue compared to the comparable quarter for the previous year is primarily attributable to an increase in the number of new hospital customers using AGGRASTAT and the increase in market share held by the product. Revenue growth was also aided by favourable fluctuations in the U.S. dollar exchange rate throughout the first quarter.

Medicure Inc. to Report Q1, 2015 Results on Apr 29, 2015

Medicure Inc. announced that they will report Q1, 2015 results After-Market on Apr 29, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MPH:CN C$2.50 CAD 0.00

MPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MPH.
View Industry Companies

Industry Analysis


Industry Average

Valuation MPH Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICURE INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at